Dr. David Kessler, Chief Scientist for Biden Administration, Calls for Proactive Use of Monoclonal Antibodies to Treat COVID-19

All we can say is: finally! While it is long overdue, we were delighted to see Dr. David Kessler, the Chief Scientist for the Biden Administration’s COVID-19 Task Force, in an interview with Rachel Madow of MSNBC, give a full throated endorsement and call for both the public and medical community to embrace and use monoclonal antibodies early and pro-actively as a critical tool to reduce hospitalizations and deaths. Noting that to this day, only 30% of the available supply has been used, he stressed that this could be reducing hospitalizations and saving lives in this critical phase as we wait for vaccines to roll-out. Dr. Kessler also emphasized the critical importance of early diagnosis and treatment – these drugs must be used within the first 7 – 10 days, PRIOR TO HOSPITALIZATION, to be effective.

Dr. Kessler directed viewers to this page on the CombatCOVID.hhs.gov Web site that the government has set up to provide guidance and information for at-risk individuals:

We hope that his marks the turning point for this critical tool to be used effectively and widely. Moreover, hopefully this realization now at the very top of the administration will prompt a focused effort to ramp up production further. COVID-19 is here to stay, and the abundant supply of an effective treatment is a critical piece of the strategy both now and for the long term.

MORE INFORMATION:

Information and Guidance on treatment with Monoclonal Antibodies for High Risk Individuals
Dr. David Kessler, Chief Scientist for Biden Administration, Calls for Proactive Use of Monoclonal Antibodies to Treat COVID-19
Scroll to top